Menu
  • Home
  • About Us
    • About 340B Report
    • Who We Are
    • Testimonials
    • Work With 340B Report
    • Contact
  • Subscribe Now
  • Document Center
  • Expert Directory
  • Events Calendar
  • Industry Insights
  • Sponsor/Advertise
  • Sign in
340B Report

340B Report

Category: Legislative

Senate Democratic Chairs-in-Waiting Waste No Time Going to Bat for 340B Providers

In Federal, Legislative, Pharma Industry, RegulatoryJanuary 12, 2021 Tom Mirga
The incoming Democratic chairs of two key U.S. Senate committees want the federal agency in charge of the 340B program “to take immediate action to clarify that implementation of a rebate model by [drug] manufacturers would violate a material condition …
Read More »

BREAKING: Amgen Ending 340B-Like Price Reductions on Orphan Drugs on Jan. 1 (Updated)

In Breaking, Legislative, Pharma IndustryDecember 9, 2020 Tom Mirga
…
Read More »

BREAKING: Bipartisan Group of 217 U.S. Representatives Ask HHS to Stop 340B Rebate Model and Look Into Third Party Vendors

In Breaking, Federal, Legislative, Other Industry, Pharma Industry, RegulatoryNovember 13, 2020 Tom Mirga
…
Read More »

U.S. Sen. Braun Introduces Bill to Collect and Report 340B Hospital Data

In Federal, Legislative, RegulatoryNovember 5, 2020 Tom Mirga
…
Read More »

GOP Committee Leaders Asked for and Got 340B Reform Ideas. What Happens Now?

In Federal, LegislativeNovember 3, 2020 Tom Mirga
…
Read More »

Iowa’s U.S. Senators Meet With HHS Top Brass About Pharma’s 340B Moves

In Federal, Legislative, Pharma Industry, RegulatoryOctober 27, 2020 Tom Mirga

Iowa’s U.S. senators—Chuck Grassley and Joni Ernst, both Republicans—met with top HHS officials yesterday to relay Iowa hospitals’ concerns about pharmaceutical manufacturers’ recent denials of 340B pricing
…
Read More »

U.S. House Democrats and Republicans “Deeply Concerned” About 340B Rebate Model

In Federal, Legislative, RegulatoryOctober 22, 2020 Tom Mirga

Clockwise from top left, U.S. Reps. Abigail D. Spanberger (D-Va.), Cindy Axne (D-Iowa), David McKinley (R-W.Va.), Doris Matsui (D-Calif.), John Katko (R-N.Y.), and Dusty Johnson (R-S.D.) are

…
Read More »

BREAKING: Congressional GOP Committee Leaders Seek 340B Reform Ideas by Oct. 30

In Breaking, Federal, LegislativeOctober 9, 2020 Tom Mirga

340B program changes “are needed and
…
Read More »

More than Half of Health Care Industry Execs Expect 340B Reporting Requirements Within Five Years

In Legislative, Other Industry, Pharma Industry, Regulatory, Research/ReportsOctober 8, 2020 Tom Mirga
SPONSORED BY


A

…
Read More »

Supreme Court ACA Overturn Could Cut Rural Hospitals from 340B, Gut HRSA Enforcement

In Federal, Judicial, Legislative, RegulatorySeptember 22, 2020 Tom Mirga
SPONSORED BY


…

Read More »

Posts navigation

1 2 3 4

Site Sidebar

Categories

  • Breaking
  • Federal
  • Judicial
  • Legislative
  • Non-Governmental
  • Other Industry
  • Pharma Industry
  • Regulatory
  • Research/Reports
  • State
  • Trade Association
  • Uncategorized

Recent Posts

  • Important Information About Accessing 340B Report
  • Health Centers File 340B Dispute Resolution Petitions Against Drug Manufacturers
  • Lilly Asks Court to Shield it From “Crippling” 340B Sanctions
  • Nevada ADAP Postpones Controversial 340B Policy Change
  • Top 10 Issues to Consider in 2021

Site Footer

Terms of Use Privacy Policy